CBDO at Gelatex | Nanofiber-based drug delivery and 3D cell culture platforms for pharma and biotech partnerships
About
I lead business development at Gelatex Technologies, where we use our HaloSpinning nanofiber platform to create drug delivery systems, wound care materials and Gelacell 3D cell culture tools. I focus on partnerships with pharma and biotech on controlled release, immune-competent in vitro models and regenerative medicine.
Pharmacology / Toxicology
Drug Delivery
Tissue Engineering
Expertise
3D Cell Culture
Organoids / iPSC models
Wound Healing
Combination Products
Intellectual Property / Patents